PNRI-299 is primarily utilized in the field of medical research, particularly in the study of neurodegenerative diseases. It has shown potential in modulating specific biological pathways that are implicated in conditions such as Alzheimer's disease and Parkinson's disease. Researchers are exploring its efficacy in reducing neuronal damage and improving cognitive functions in preclinical models. Additionally, PNRI-299 is being investigated for its role in enhancing neuroprotection and potentially slowing the progression of these debilitating disorders. Its application extends to the development of therapeutic agents aimed at targeting the underlying mechanisms of neurodegeneration, offering hope for future treatments.